Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures

NCT ID: NCT06533904

Last Updated: 2025-10-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are:

Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium?

Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery.

Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trauma Rib Fractures Chest Wall Disorder Respiratory Insufficiency Pain, Chest Rib Trauma Rib Fracture Multiple Respiratory Failure Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Patients will be randomized to standard multi-modal pain regimen with percutaneous cryoablation versus standard multi-modal pain regimen alone.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard multi-modal pain regimen alone

Group Type PLACEBO_COMPARATOR

Multi-modal pain regimen

Intervention Type OTHER

Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)

Standard multi-modal pain regimen with percutaneous cryoablation

Group Type EXPERIMENTAL

Percutaneous Cryoablation of Intercostal Nerves

Intervention Type PROCEDURE

Percutaneous Cryoablation of Intercostal Nerves

Multi-modal pain regimen

Intervention Type OTHER

Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous Cryoablation of Intercostal Nerves

Percutaneous Cryoablation of Intercostal Nerves

Intervention Type PROCEDURE

Multi-modal pain regimen

Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \> 18 years old
* \> 2 rib fractures
* Verbal Pain score \> 5
* Incentive Spirometry \< 60% of predicted

Exclusion Criteria

* Isolated Fractures of Ribs 1-3 and/or 10-12
* Posterior Rib Fracture \< 4 cm from costovertebral joint
* Sternal, Clavicle, Scapula Fracture
* Thoracic Spinal Fracture of any type
* Open Abdominothoracic Surgery
* Unstable Spine
* Extensive Subcutaneous Emphysema
* BMI \> 35
* Plan for Rib Plating
* Chronic Opioid Use
* Prior to study enrollment: Intubated, Traumatic Brain Injury, Dementia, Cognitive Impairment, Encephalopathy
* Coagulopathy, Shock at time of ablation
* Inability to participate in activities of daily living prior to injury
* Home O2 use prior to trauma
* Inhalation Injury
* Rib Fractures due to cardiopulmonary resuscitation
* Life Expectancy \< 6 months
* \> 48 hours from injury
* Pregnant, Incarcerated
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Loma Linda University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda University Health

Loma Linda, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Martin G Rosenthal, MD

Role: primary

909-558-4286

Matthew E Reeves, MD

Role: backup

909-558-4289

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5240003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PEF-Block & Ribs Fractures
NCT03396692 COMPLETED NA
Thoracic Epidural Analgesia in Flail Chest
NCT03413059 UNKNOWN PHASE2/PHASE3
A Study of Paravertebral Block in Thoracic Outlet Syndrome
NCT05544721 ENROLLING_BY_INVITATION PHASE4